Emergent BioSolutions Inc
EBS5.820USD
+0.190+3.37%
交易中 （美東）報價延遲15分鐘
317.19M總市值
虧損本益比TTM
關於 Emergent BioSolutions Inc 公司
Emergent BioSolutions, Inc. 是一家生命科學公司。該公司專注於提供應對意外、故意和自然發生的公共衛生威脅的準備和響應解決方案。其解決方案包括產品組合、產品開發組合和生物服務組合。其部門包括商業產品、MCM 產品和服務部門。商業產品部門包括 NARCAN（鹽酸納洛酮）。MCM 產品部門包括炭疽 - MCM、天花 - MCM 和其他產品。服務部門包括其生物服務產品。NARCAN（鹽酸納洛酮）鼻噴霧劑是一種納洛酮鼻腔製劑，用於緊急治療已知或疑似阿片類藥物過量，表現爲呼吸和/或中樞神經系統抑制。其生物服務組合由三個相互關聯的服務支柱組成，例如開發服務（工藝和分析開發）和藥物物質製造。
公司簡介
公司代碼EBS
公司名稱Emergent BioSolutions Inc
上市日期Nov 15, 2006
CEOMr. Joseph C. (Joe) Papa
員工數量900
證券類型Ordinary Share
年結日Nov 15
公司地址300 Professional Dr
城市GAITHERSBURG
上市交易所NYSE Consolidated
國家United States of America
郵編20879
電話12406313200
網址https://emergentbiosolutions.com/
公司代碼EBS
上市日期Nov 15, 2006
CEOMr. Joseph C. (Joe) Papa
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+21.24%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
201.49K
-1.34%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
121.47K
-1.02%
The Hon. Dr. Louis W. Sullivan, M.D.
The Hon. Dr. Louis W. Sullivan, M.D.
Independent Director
Independent Director
118.86K
+40.74%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+49.80%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
91.98K
+211.99%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
85.27K
+67.63%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
68.39K
+1061.66%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
68.25K
+101.64%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
66.14K
-10.60%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+21.24%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
201.49K
-1.34%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
121.47K
-1.02%
The Hon. Dr. Louis W. Sullivan, M.D.
The Hon. Dr. Louis W. Sullivan, M.D.
Independent Director
Independent Director
118.86K
+40.74%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+49.80%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
91.98K
+211.99%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
MCM Product sales
156.60M
70.48%
Commercial Product sales
45.30M
20.39%
Contracts and grants
20.30M
9.14%
地區USD
名稱
營收
佔比
Non-U.S Government
143.40M
64.54%
U.S.Government
78.80M
35.46%
業務
地區
業務USD
名稱
營收
佔比
MCM Product sales
156.60M
70.48%
Commercial Product sales
45.30M
20.39%
Contracts and grants
20.30M
9.14%
股東統計
更新時間: 5月22日 週四
更新時間: 5月22日 週四
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
5.92%
Millennium Management LLC
4.61%
American Century Investment Management, Inc.
4.23%
State Street Global Advisors (US)
3.15%
Dimensional Fund Advisors, L.P.
2.94%
Other
79.14%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
5.92%
Millennium Management LLC
4.61%
American Century Investment Management, Inc.
4.23%
State Street Global Advisors (US)
3.15%
Dimensional Fund Advisors, L.P.
2.94%
Other
79.14%
股東類型
持股股東
佔比
Investment Advisor
26.89%
Investment Advisor/Hedge Fund
20.51%
Hedge Fund
14.34%
Research Firm
4.30%
Individual Investor
3.04%
Pension Fund
1.04%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.17%
Venture Capital
0.16%
Other
28.88%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
443
38.62M
71.16%
-7.77M
2025Q1
472
38.22M
70.45%
-8.61M
2024Q4
475
36.31M
66.90%
-8.91M
2024Q3
485
33.46M
61.86%
-11.26M
2024Q2
503
32.16M
60.76%
-21.31M
2024Q1
512
37.52M
71.59%
-17.68M
2023Q4
531
43.49M
83.79%
-11.00M
2023Q3
581
43.88M
84.66%
-15.71M
2023Q2
596
48.59M
93.79%
-8.52M
2023Q1
682
47.08M
93.36%
-12.05M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
3.21M
5.92%
+13.30K
+0.42%
Mar 31, 2025
Millennium Management LLC
2.50M
4.61%
+1.02M
+68.87%
Mar 31, 2025
American Century Investment Management, Inc.
2.30M
4.23%
+159.91K
+7.48%
Mar 31, 2025
State Street Global Advisors (US)
1.71M
3.15%
-253.01K
-12.88%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.60M
2.94%
+492.58K
+44.62%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.58M
2.92%
-61.06K
-3.71%
Mar 31, 2025
Marshall Wace LLP
1.16M
2.13%
-170.78K
-12.85%
Mar 31, 2025
Palisade Capital Management, LLC
1.14M
2.1%
+202.86K
+21.61%
Mar 31, 2025
Oak Hill Advisors, L.P.
1.11M
2.05%
--
--
Mar 31, 2025
Qube Research & Technologies Ltd
1.09M
2%
+271.55K
+33.29%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Harbor Human Capital Factor US Small Cap ETF
0.15%
Invesco RAFI US 1500 Small-Mid ETF
0.14%
SPDR S&P Biotech ETF
0.13%
Federated Hermes MDT Small Cap Core ETF
0.1%
Pacer US Small Cap Cash Cows ETF
0.09%
iShares Micro-Cap ETF
0.08%
Avantis US Small Cap Value ETF
0.08%
Direxion Daily S&P Biotech Bull 3X Shares
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Avantis US Small Cap Equity ETF
0.04%
查看更多
Harbor Human Capital Factor US Small Cap ETF
佔比0.15%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.14%
SPDR S&P Biotech ETF
佔比0.13%
Federated Hermes MDT Small Cap Core ETF
佔比0.1%
Pacer US Small Cap Cash Cows ETF
佔比0.09%
iShares Micro-Cap ETF
佔比0.08%
Avantis US Small Cap Value ETF
佔比0.08%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.05%
Avantis US Small Cap Equity ETF
佔比0.04%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
